View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Carfilzomib 36 / Cyclophosphamide 300 / Dexamethasone 40, Multiple Myeloma, Cycle 2-9, Variant 1
Protocol-ID: 1459 V1.1 (Mini), CARF36/CYCL300/DEXA40, MM, C2-9, var. 1Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
Links
- Carfilzomib and Dexamethasone in Combination With Cyclophosphamide vs. Carfilzomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: a Phase II Randomized Controlled Trial, PETHEMA Foundation [clinicaltrials.gov]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 05.06.2021